Madison Avenue Partners, LP - Significant Ownership

Signature - Title
s/ Eli Samaha - Eli Samaha, as Managing Member of EMAI Management, LLC, the General Partner of Madison Avenue Partners, LP
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Madison Avenue Partners, LP.

Significant Ownership of Madison Avenue Partners, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SAGE Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock") 9.7% $52.7M $10M 6.08M +23.5% Madison Avenue Partners LP Jun 30, 2025
CRGX CARGO Therapeutics, Inc. Common stock, par value $0.001 per share (the "Common Stock") 9.1% $18.7M $4.83M 4.19M +34.7% Madison Avenue Partners LP Jun 30, 2025
KROS Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (the "Common Stock") 6.4% $32M 2.61M Madison Avenue Partners, LP May 7, 2025
INDV Indivior PLC Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") 6% $66.5M 7.44M Madison Avenue International LP Mar 11, 2025
SLRN ACELYRIN, Inc. Common Stock 5.1% $11.3M 5.09M Madison Avenue Partners, LP Apr 29, 2025
WLY John Wiley & Sons, Inc. Class A Common Stock, par value $1.00 per share (the "Common Stock") 4.95% $92.5M 2.23M Madison Avenue Partners, LP Dec 31, 2024
OVID Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (the "Common Stock") 4% $890K 2.85M Madison Avenue Partners, LP Dec 31, 2024

Schedules 13D/G Reported by Madison Avenue Partners, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.